Related Experiment Video

Updated: Aug 28, 2025

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.6K

What do we actually know about exosomal microRNAs in kidney diseases?

Qianyu Li1, Zhiping Zhang1, Min Yin1

  • 1Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, China.

Frontiers in Physiology
|September 15, 2022
PubMed

Insights

Exosomal microRNAs show promise for early kidney disease diagnosis and treatment. Analyzing these microRNAs in exosomes can reveal disease status and guide therapeutic strategies for renal diseases.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Kidney diseases can lead to irreversible end-stage renal disease if untreated.
  • Early diagnosis and targeted treatment are crucial for managing kidney diseases.
  • Exosomes, secreted by renal cells, are valuable carriers of biomolecules like microRNAs.

Purpose of the Study:

  • To review changes in exosomal microRNA expression across various kidney diseases.
  • To highlight the diagnostic and prognostic potential of exosomal microRNAs in renal conditions.
  • To analyze the role of exosomal microRNAs in kidney disease development and guide therapeutic strategies.

Main Methods:

  • Literature review of studies on exosomal microRNA expression in kidney diseases.
  • Analysis of diagnostic and prognostic value of identified exosomal microRNAs.
  • Investigation into the molecular mechanisms and therapeutic implications of exosomal microRNAs.

Main Results:

  • Exosomal microRNA expression profiles differ significantly across various kidney diseases.
  • Specific exosomal microRNAs demonstrate potential as biomarkers for early diagnosis and prognosis.
  • Exosomal microRNAs play roles in the pathogenesis of different renal diseases.

Conclusions:

  • Exosomal microRNAs are promising diagnostic and prognostic biomarkers for kidney diseases.
  • Understanding exosomal microRNA roles can advance research into molecular mechanisms.
  • Targeting exosomal microRNAs may offer novel therapeutic strategies for renal diseases.
Keywords:
biomarkersexosomekidney diseasemicroRNAphysiology

More Related Videos

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model07:01

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

Published on: September 11, 2020

1.5K
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.5K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.3K
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
3.1K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
21
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
266